Carregant...
Miniatura

Tipus de document

Article

Versió

Versió publicada

Data de publicació

Llicència de publicació

cc-by (c) Herráez, Rocio et al., 2021
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/181172

Tambjamines and prodiginines: biocidal activity against trypanosoma cruzi

Títol de la revista

Director/Tutor

ISSN de la revista

Títol del volum

Resum

The aim of this work was to explore new therapeutic options against Chagas disease by the in vitro analysis of the biocidal activities of several tambjamine and prodiginine derivatives, against the Trypanosoma cruzi CLB strain (DTU TcVI). The compounds were initially screened against epimastigotes. The five more active compounds were assayed in intracellular forms. The tambjamine MM3 and both synthetic and natural prodigiosins displayed the highest trypanocidal profiles, with IC50 values of 4.52, 0.46, and 0.54 µM for epimastigotes and 1.9, 0.57, and 0.1 µM for trypomastigotes/amastigotes, respectively. Moreover, the combination treatment of these molecules with benznidazole showed no synergism. Finally, oxygen consumption inhibition determinations performed using high-resolution respirometry, revealed a potent effect of prodigiosin on parasite respiration (73% of inhibition at ½ IC50), suggesting that its mode of action involves the mitochondria. Moreover, its promising selectivity index (50) pointed out an interesting trypanocidal potential and highlighted the value of prodigiosin as a new candidate to fight Chagas disease.

Citació

Citació

HERRÁEZ, Rocio, QUESADA, Roberto, DAHDAH, Norma, VIÑAS, Miquel, VINUESA AUMEDES, Teresa. Tambjamines and prodiginines: biocidal activity against trypanosoma cruzi. _Pharmaceutics_. 2021. Vol. 13, núm. 5, pàgs. 705. [consulta: 3 de febrer de 2026]. ISSN: 1999-4923. [Disponible a: https://hdl.handle.net/2445/181172]

Exportar metadades

JSON - METS

Compartir registre